Newton, MA–(business wire) — LabShares Newton, a shared office and lab incubator for emerging life sciences companies, today announced that it has selected two winners of its 2022 [email protected] pitch competition. [email protected] was launched in 2018 as an effort to help exciting early-stage startups develop clear, sound plans for research, growth, and pathways to positive patient outcomes.
Winners, Interon Labs and Proteinea, will receive a free bench for one year in LabShares’ well-equipped BL2 space. Prizes also include office space, full access to all LabShares services and facilities, and use of state-of-the-art equipment. [email protected] is generously sponsored by DT Ward PC, Faber Daeufer & Itrato, ThermoFisher Scientific, Tobin Scientific, and Safety Partners, Inc.
LabShares CEO Jeff Behrens said: Immunology and protein discovery/optimization. ”
Already a LabShares resident, Interon Labs is looking to expand its footprint in 2023. Interon is a pioneer in brain immunotherapy, developing treatments for autism and other neurological disorders. Interon’s groundbreaking science includes discoveries by Interon’s co-founder, his MIT and Harvard medical schools, and have been featured in journals such as Nature, Science, and Cell.
“LabShares has been a tremendous ally in advancing scientific and business progress at Interon,” said Paul Singh, CEO of Interon Laboratories. “Both Labshares and Interon share a common goal of solving complex human health problems, and we look forward to expanding our partnership together.”
The second winner, Proteinea, was founded in Egypt and aims to deliver next-generation full-stack biomanufacturing technologies that make protein therapeutics more accessible through innovative design and manufacturing methods. Using a proprietary computational platform and protein language model, Proteinea focuses on Fc optimization/modification and the ability to design new modalities more quickly and effectively to address the challenging challenges inherent in antibody design. solve the problem.
Mahmoud Eljendy, Founder and CEO of Proteinia, said: The company was born in Egypt and now expands to Boston, enabling more antibody and cell therapy developers to efficiently utilize better modalities using our powerful computational platform. increase. ”
About LabShares Newton
LabShares Newton is an office and BL2 lab incubator for emerging biotech and life science start-ups, offering options for shared lab spaces or private lab suites. LabShares’ goal is to provide best-in-class services, facilities, and equipment for startups of all sizes and stages. For more information about LabShares or to arrange a tour, please contact [email protected].
